Clinical trial
Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat
NCT00402987 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00402987 |
|---|---|
| Title | Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat |
| Official title | A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED COMPARISON OF THE EFFICACY, SAFETY, AND TOLERABILITY OF CELECOXIB 100-150 MG, INCLUDING INITIAL DOSES OF 50 AND 100 MG, AND PLACEBO IN THE SYMPTOMATIC TREATMENT OF PATIENTS WITH PAINFUL PHARYNGITIS |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pharyngitis |
| Intervention type | Drug |
| Interventions | Celecoxib, celecoxib, placebo |
| Enrollment | 269 |
| Start date | Dec 4, 2006 |
| Primary completion | Nov 15, 2007 |
| Completion | Nov 15, 2007 |
| First posted | Nov 23, 2006 |
| Last update posted | Mar 3, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: